ACSR Partners with Proscia to Accelerate Global HIV Cancer Research Through Advanced Digital Pathology Platform

In a recent development for the scientific community, the AIDS and Cancer Specimen Resource (ACSR) has enhanced its ability to …

Continue ›››

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …

Continue ›››

Tech-First Companies Take the Lead in AI Drug Discovery

In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …

Continue ›››

Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race

Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …

Continue ›››

Eight Approaches to Leveraging AI in Clinical Trials with the Key Industry Innovators

In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety …

Continue ›››

Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals

The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …

Continue ›››

Will Biologics Surpass Small Molecules In The Pharmaceutical Race?

The first biologics drug, humanized insulin (5.8 kDa), became available in 1982 following the advent of biotechnology, and it marked …

Continue ›››

From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials

As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …

Continue ›››

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …

Continue ›››

Navigating Data Scarcity: AI's Emerging Role in Biotech

‘Garbage in, garbage out’ is a well-known principle in the machine learning (ML) community, and it is certainly true when …

Continue ›››

How Lithuania's Deep Tech Ecosystem Is Fueling the Country's Life Sciences Boom

From gene editing and artificial intelligence (AI)-driven protein design, to cutting-edge 3D bioprinting, tissue engineering and microfluidics – Lithuania appears …

Continue ›››

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …

Continue ›››